Crizotinib in ALK+ inflammatory myofibroblastic tumors—Current experience and future perspectives
- 29 December 2017
- journal article
- review article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 65 (4)
Abstract
Inflammatory myofibroblastic tumor (IMT) and its subtype epithelioid inflammatory myofibroblastic sarcoma (EIMS) are rare soft‐tissue tumors. As about 50% of IMT and 100% of EIMS contain activating rearrangements of the anaplastic lymphoma kinase (ALK) gene, targeted kinase inhibition of ALK by compounds such as crizotinib is a potential treatment option. We performed a literature review and analyzed a total of 30 patients with IMT/EIMS treated with crizotinib. A total of 12 patients achieved complete or partial remission. As preliminary data are promising, a prospective study evaluating crizotinib treatment in patients with unresectable/multifocal ALK+ IMT/EIMS is warranted.Keywords
This publication has 37 references indexed in Scilit:
- Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium studyThe Lancet Oncology, 2013
- Epithelioid Inflammatory Myofibroblastic SarcomaAmerican Journal of Surgical Pathology, 2011
- Crizotinib inALK-Rearranged Inflammatory Myofibroblastic TumorNew England Journal of Medicine, 2010
- Inflammatory myofibroblastic tumours: where are we now?Journal of Clinical Pathology, 2007
- Inflammatory Myofibroblastic TumorAmerican Journal of Surgical Pathology, 2007
- ALK1 and p80 Expression and Chromosomal Rearrangements Involving 2p23 in Inflammatory Myofibroblastic TumorLaboratory Investigation, 2001
- TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic TumorsThe American Journal of Pathology, 2000
- ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)Oncogene, 1997
- Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous systemOncogene, 1997
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994